Nexalin Technology (NXL) Accounts Payables (2021 - 2026)
Nexalin Technology (NXL) posted Accounts Payables of $239448.0 for Q2 2026, up 42.44% on a QoQ basis from $168099.0 in Q1 2026, and little changed year-over-year from $240580.0 in Q2 2025.
Analysis
Nexalin Technology (NXL) Accounts Payables (2021 - 2026) Analysis & Trends
Nexalin Technology has reported Accounts Payables for 6 years, with the latest figure at $239448.0 in Q2 2026.
- On a quarterly basis, Accounts Payables changed 0.47% year-over-year to $239448.0 in Q2 2026; TTM through Jun 2026 was $239448.0, a 0.47% change from a year earlier, with the FY2025 full-year figure at $244579.0, up 56.83% from the prior year.
- Accounts Payables was $239448.0 for Q2 2026 at Nexalin Technology, up from $168099.0 in the prior quarter.
- The five-year high for Accounts Payables was $788293.0 in Q3 2022, with the low at $48501.0 in Q2 2023.
- Average Accounts Payables over 5 years is $217795.9, with a median of $163038.0 recorded in 2023.
- The sharpest annual moves came in 2023 and 2024: Accounts Payables tumbled 90.8% in 2023, then soared 176.69% in 2024.
- Over 5 years, Accounts Payables stood at $658367.0 in 2022, then plunged by 75.77% to $159534.0 in 2023, then dropped by 2.25% to $155949.0 in 2024, then soared by 56.83% to $244579.0 in 2025, then dropped by 2.1% to $239448.0 in 2026.
- The last three Accounts Payables figures came in at $239448.0 (Q2 2026), $168099.0 (Q1 2026), and $244579.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 4.79 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 277.20 Mn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 2.70 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 1.66 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 1.23 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 210.50 Mn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 968.00 Mn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | - |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 344.10 Mn |
| 10 | Nexalin Technology | 3.44 Mn | 2.44 Mn | 8,897.00 | 239,448.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 239,448.00 |
| Mar 31, 2026 | 168,099.00 |
| Dec 31, 2025 | 244,579.00 |
| Sep 30, 2025 | 67,493.00 |
| Jun 30, 2025 | 240,580.00 |
| Mar 31, 2025 | 181,394.00 |
| Dec 31, 2024 | 155,949.00 |
| Sep 30, 2024 | 166,542.00 |
| Jun 30, 2024 | 87,138.00 |
| Mar 31, 2024 | 151,510.00 |
| Dec 31, 2023 | 159,534.00 |
| Sep 30, 2023 | 72,549.00 |
| Jun 30, 2023 | 48,501.00 |
| Mar 31, 2023 | 54,758.00 |
| Dec 31, 2022 | 658,367.00 |
| Sep 30, 2022 | 788,293.00 |
| Dec 31, 2021 | 843,794.00 |